rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
2005-5-9
|
pubmed:abstractText |
Calcineurin inhibitors and steroids are standard immunosuppressants in solid organ transplantation, but (long-term) side effects are harmful to the recipient and the graft. The authors present a novel strategy for posttransplant immunosuppression that combines a depleting antibody with an antimetabolite, avoiding calcineurin inhibitors and steroids.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0041-1337
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
79
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1184-9
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:15880067-Antibodies, Monoclonal,
pubmed-meshheading:15880067-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:15880067-Antibodies, Neoplasm,
pubmed-meshheading:15880067-Calcineurin,
pubmed-meshheading:15880067-Graft Rejection,
pubmed-meshheading:15880067-Graft Survival,
pubmed-meshheading:15880067-Humans,
pubmed-meshheading:15880067-Immunosuppression,
pubmed-meshheading:15880067-Immunosuppressive Agents,
pubmed-meshheading:15880067-Infection,
pubmed-meshheading:15880067-Kidney Transplantation,
pubmed-meshheading:15880067-Pancreas Transplantation,
pubmed-meshheading:15880067-Postoperative Complications,
pubmed-meshheading:15880067-Retrospective Studies,
pubmed-meshheading:15880067-Survival Analysis,
pubmed-meshheading:15880067-Time Factors,
pubmed-meshheading:15880067-Treatment Outcome
|
pubmed:year |
2005
|
pubmed:articleTitle |
Calcineurin inhibitor- and steroid-free immunosuppression in pancreas-kidney and solitary pancreas transplantation.
|
pubmed:affiliation |
Department of Surgery, University of Minnesota, Minneapolis, MN 55455, USA. grues001@umn.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|